Published in JAMA on July 03, 1991
The effects of immune status and race on health service use among people with HIV disease. Am J Public Health (1993) 1.14
Gamma interferon stimulates rat alveolar macrophages to kill Pneumocystis carinii by L-arginine- and tumor necrosis factor-dependent mechanisms. Infect Immun (1999) 0.93
Survival with AIDS in Massachusetts, 1979 to 1989. Am J Public Health (1993) 0.88
The effect of human immunodeficiency virus infection on the distribution and outcome of pneumonia in intensive care units. West J Med (1992) 0.81
Clinical computing in a teaching hospital. N Engl J Med (1985) 5.23
Rapid enzymatic measurement of blood lactate and pyruvate. Use and significance of metaphosphoric acid as a common precipitant. Clin Chem (1967) 4.13
Therapeutic hypothermia after cardiac arrest: an advisory statement by the advanced life support task force of the International Liaison Committee on Resuscitation. Circulation (2003) 3.40
End-tidal carbon dioxide concentration during cardiopulmonary resuscitation. N Engl J Med (1988) 2.80
Experimental and clinical studies on lactate and pyruvate as indicators of the severity of acute circulatory failure (shock). Circulation (1970) 2.72
A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med (1996) 2.38
The relation of age, race, and gender to the subsite location of colorectal carcinoma. Cancer (1997) 2.35
Buffer solutions may compromise cardiac resuscitation by reducing coronary perfusion presssure. JAMA (1991) 2.15
Gastric intramural PCO2 during peritonitis and shock. Chest (1993) 2.13
Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. J Neurosurg (1998) 2.13
The conditional probability of survival of patients with primary malignant brain tumors: surveillance, epidemiology, and end results (SEER) data. Cancer (1999) 2.12
Temperature of the great toe as an indication of the severity of shock. Circulation (1969) 2.10
Factors associated with survival in patients with meningioma. J Neurosurg (1998) 2.06
Clinical features, site of involvement, bacteriologic findings, and outcome of infective endocarditis in intravenous drug users. Arch Intern Med (1995) 2.03
Brain tumor survival: results from the National Cancer Data Base. J Neurooncol (1998) 1.98
Airway protection during experimental CPR. Chest (1995) 1.96
Decreases in mortality on a large urban medical service by facilitating access to critical care. An alternative to rationing. Arch Intern Med (1988) 1.86
Antiphospholipid antibodies, proteins C and S, and coagulation changes in sickle cell disease. J Lab Clin Med (1999) 1.82
Survival rates and prehospital delay during myocardial infarction among black persons. Am J Cardiol (1986) 1.82
Clinically relevant differences between the statins: implications for therapeutic selection. Am J Med (2001) 1.82
Venous hypercarbia associated with severe sepsis and systemic hypoperfusion. Crit Care Med (1990) 1.74
Optimizing timing of ventricular defibrillation. Crit Care Med (2001) 1.74
Cardiac output and end-tidal carbon dioxide. Crit Care Med (1985) 1.71
Epinephrine increases the severity of postresuscitation myocardial dysfunction. Circulation (1995) 1.68
Difference in acid-base state between venous and arterial blood during cardiopulmonary resuscitation. N Engl J Med (1986) 1.66
Effects of caffeine on muscle glycogen utilization and the neuroendocrine axis during exercise. J Clin Endocrinol Metab (2000) 1.65
Ethanol increases extracellular adenosine by inhibiting adenosine uptake via the nucleoside transporter. J Biol Chem (1990) 1.63
Comparisons between sublingual and gastric tonometry during hemorrhagic shock. Chest (2000) 1.62
Relationship of oxygen delivery and mixed venous oxygenation to lactic acidosis in patients with sepsis and acute myocardial infarction. Crit Care Med (1988) 1.58
Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups. Neuro Oncol (2001) 1.57
Hepatic artery adjuvant chemotherapy for patients having resection or ablation of colorectal cancer metastatic to the liver. Cochrane Database Syst Rev (2006) 1.54
An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users. J Infect Dis (1996) 1.51
Prescribe for health. Improving cancer screening in physician practices serving low-income and minority populations. Arch Fam Med (1998) 1.50
The effects of biphasic and conventional monophasic defibrillation on postresuscitation myocardial function. J Am Coll Cardiol (1999) 1.50
Expired carbon dioxide: a noninvasive monitor of cardiopulmonary resuscitation. Circulation (1988) 1.50
Peripheral vascular tone in sepsis. Chest (1991) 1.47
Pulmonary ventilation/perfusion defects induced by epinephrine during cardiopulmonary resuscitation. Circulation (1991) 1.46
Rectal administration of metronidazole provides therapeutic plasma levels in postoperative patients. N Engl J Med (1981) 1.45
Increased venous-arterial carbon dioxide tension difference during severe sepsis in rats. Crit Care Med (1994) 1.44
Unaccounted for anion in metabolic acidosis during severe sepsis in humans. Crit Care Med (1991) 1.40
Dictation in the presence of the patient. Arch Fam Med (1998) 1.39
Competent and continuing care of the critically ill. Crit Care Med (1988) 1.39
Monophosphoryl lipid A attenuates the effects of endotoxic shock in pigs. J Lab Clin Med (1992) 1.38
The effects of PCB exposure and fish consumption on endogenous hormones. Environ Health Perspect (2001) 1.38
Hypothermia after cardiac arrest. Crit Care Med (1991) 1.37
High-energy defibrillation increases the severity of postresuscitation myocardial dysfunction. Circulation (1997) 1.36
Plasmid-determined silver resistance in Pseudomonas stutzeri isolated from a silver mine. J Bacteriol (1984) 1.33
A primitive enzyme for a primitive cell: the protease required for excystation of Giardia. Cell (1997) 1.25
Arteriovenous carbon dioxide and pH gradients during cardiac arrest. Circulation (1986) 1.24
Effect of phenobarbitone on hepatic drug-metabolizing enzymes and urinary D-glucaric acid excretion in man. Br J Clin Pharmacol (1975) 1.23
Cardiac arrest in the critically ill. I. A study of predisposing causes in 132 patients. Circulation (1971) 1.22
Colloid oncotic pressure: clinical significance. Crit Care Med (1979) 1.20
Trends in incidence of primary brain tumors in the United States, 1985-1994. Neuro Oncol (2001) 1.19
Severe family violence and Alzheimer's disease: prevalence and risk factors. Gerontologist (1992) 1.17
Coagulation changes in individuals with sickle cell trait. Am J Hematol (2002) 1.16
Hemodynamic and metabolic studies on shock associated with gram negative bacteremia. Medicine (Baltimore) (1973) 1.16
Electrical bioimpedance for noninvasive measurement of cardiac output. Crit Care Med (1997) 1.15
Arterial PCO2 as an indicator of systemic perfusion during cardiopulmonary resuscitation. Crit Care Med (1989) 1.13
Age and readiness to quit smoking. Prev Med (1994) 1.13
Proposed reclassification of shock states with special reference to distributive defects. Adv Exp Med Biol (1971) 1.12
Comparison of blood lactate concentrations in central venous, pulmonary artery, and arterial blood. Crit Care Med (1987) 1.12
Myocardial dysfunction after successful resuscitation from cardiac arrest. Crit Care Med (1996) 1.12
Pulmonary edema related to changes in colloid osmotic and pulmonary artery wedge pressure in patients after acute myocardial infarction. Circulation (1975) 1.11
Assessment of painful episode frequency in sickle-cell disease. Am J Hematol (1997) 1.11
Redefining ischemia due to circulatory failure as dual defects of oxygen deficits and of carbon dioxide excesses. Crit Care Med (1991) 1.11
End-tidal CO2 as a guide to successful cardiopulmonary resuscitation: a preliminary report. Crit Care Med (1985) 1.11
Pulmonary edema during volume infusion. Circulation (1975) 1.11
Buffer agents do not reverse intramyocardial acidosis during cardiac resuscitation. Circulation (1990) 1.10
Discharge decision-making in a medical ICU: characteristics of unexpected readmissions. Crit Care Med (1983) 1.08
Triage considerations in medical intensive care. Arch Intern Med (1990) 1.07
Quantitation of severity of critical illness with special reference to blood lactate. Crit Care Med (1974) 1.07
Ethnic differences in mortality from insulin-dependent diabetes mellitus among people less than 25 years of age. Pediatrics (1999) 1.06
Sublingual capnometry for diagnosis and quantitation of circulatory shock. Am J Respir Crit Care Med (1998) 1.06
Cardiopulmonary resuscitation in the rat. J Appl Physiol (1985) (1988) 1.06
Pulmonary edema following intracranial hemorrhage. Chest (1979) 1.06
Cardiac arrest in the critically ill. II. Hyperosmolal states following cardiac arrest. Am J Med (1974) 1.04
Decreases in organ blood flows associated with increases in sublingual PCO2 during hemorrhagic shock. J Appl Physiol (1985) (1998) 1.04
Lack of trainees. Br Dent J (2012) 1.02
Ventricular fibrillation voltage as a monitor of the effectiveness of cardiopulmonary resuscitation. J Lab Clin Med (1994) 1.01
Effects of hetastarch and albumin on coagulation in patients with septic shock. J Clin Pharmacol (1988) 1.01
Attitudes and practices for smoking cessation counseling by provider type and patient age. Prev Med (1995) 1.01
Clinical characteristics and resource utilization of ICU patients: implications for organization of intensive care. Crit Care Med (1987) 1.01
Shock associated with barbiturate intoxication. JAMA (1971) 1.01
End-tidal carbon dioxide as a noninvasive indicator of cardiac index during circulatory shock. Crit Care Med (2000) 1.00
Gametophytic self-incompatibility: contrasting mechanisms for Nicotiana and Papaver. Trends Cell Biol (1993) 1.00
Oxygen delivery and consumption in patients with hyperdynamic septic shock. Crit Care Med (1987) 1.00
Progressive myocardial dysfunction after cardiac resuscitation. Crit Care Med (1993) 1.00
Cardiac output in bacterial shock. Am J Med (1978) 0.98
Selection of hemodynamic, respiratory and metabolic variables for evaluation of patients in shock. Crit Care Med (1975) 0.98
Routine plasma colloid osmotic pressure measurements. Crit Care Med (1975) 0.98
Anaphylactic shock in man. Report of two cases with detailed hemodynamic and metabolic studies. Arch Intern Med (1967) 0.98
Adverse effects of interrupting precordial compression during cardiopulmonary resuscitation. Crit Care Med (1997) 0.97
Identification of a cDNA encoding an active asparaginyl endopeptidase of Schistosoma mansoni and its expression in Pichia pastoris. FEBS Lett (2000) 0.97
New concepts in the diagnosis and fluid treatment of circulatory shock. Thirteenth annual Becton, Dickinson and Company Oscar Schwidetsky Memorial Lecture. Anesth Analg (1979) 0.97
Crystalloids, colloids, and fluid compartments. Crit Care Med (1999) 0.97
Myocardial acidosis associated with CO2 production during cardiac arrest and resuscitation. Circulation (1989) 0.96
Unmeasured anion during severe sepsis with metabolic acidosis. Circ Shock (1990) 0.96
Prothrombotic factors enhance heparin-induced thrombocytopenia and thrombosis in vivo in a mouse model. J Thromb Haemost (2006) 0.95